Skip to main content
. 2022 Mar 1;2022:6657820. doi: 10.1155/2022/6657820

Figure 3.

Figure 3

Diagnostic performances of autoantibodies against LRDD, STC1, and FOXA1 in the validation group. The red symbol represents the performance of each autoantibody in distinguishing between OC and NHC, and the blue symbol represents the performance of each autoantibody to distinguish between OC and BOD; OC: ovarian cancer; NHC: normal healthy control; BOD: benign ovarian disease; Se: sensitivity; Sp: specificity; AUC: area under the receiver operating characteristic curve.